Elvis

ELVIS V is pioneering the development of bionic brain implants designed to restore vision for blind and deaf-blind individuals by stimulating the visual cortex with microcurrents. Operating within the medical technology sector, the company focuses on creating a microcomputer and microchip system that processes visual data through neural networks, replacing the retina and optic nerve with a camera. The business model involves manufacturing and testing these implants, with plans for human trials and eventual commercial surgeries supported by the Russian Ministry of Health, charity foundations, and private sponsors. ELVIS V aims to serve both the medical community and wealthy clients seeking advanced solutions for vision restoration. The company generates revenue through the production and sale of these implants, as well as potential partnerships and sponsorships. Keywords: bionic, brain implants, vision restoration, neural stimulation, visual cortex, microchip, medical technology, human trials, surgery, Russia.